TPLNX
Price
$20.78
Change
+$0.05 (+0.24%)
Updated
Jul 31 closing price
Net Assets
183.26M
VSCIX
Price
$141.38
Change
-$0.34 (-0.24%)
Updated
Jul 31 closing price
Net Assets
188.57B
Interact to see
Advertisement

TPLNX vs VSCIX

TPLNX vs VSCIX Comparison Chart in %
View a ticker or compare two or three
VS
TPLNX vs. VSCIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TPLNX is a Hold and VSCIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSCIX has more cash in the bank: 189B vs. TPLNX (183M). VSCIX pays higher dividends than TPLNX: VSCIX (1.23) vs TPLNX (0.24). TPLNX was incepted earlier than VSCIX: TPLNX (32 years) vs VSCIX (29 years). TPLNX (1.64) is less costly to investors than VSCIX (0.03). TPLNX is a more actively managed with annual turnover of: 56.00 vs. VSCIX (17.00). TPLNX has a lower initial minimum investment than VSCIX: TPLNX (1000) vs VSCIX (5000000). VSCIX annual gain was more profitable for investors over the last year : 22.58 vs. TPLNX (9.95). VSCIX return over 5 years is better than : 35.13 vs. TPLNX (-0.08).
TPLNXVSCIXTPLNX / VSCIX
Total Expense Ratio1.500.035,000%
Annual Report Gross Expense Ratio1.640.035,467%
Fund Existence32 years29 years-
Gain YTD14.68014.591101%
Front Load6%N/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets183M189B0%
Annual Yield % from dividends0.241.2320%
Returns for 1 year9.9522.5844%
Returns for 3 years12.2443.4428%
Returns for 5 years-0.0835.13-0%
Returns for 10 years29.93156.0719%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GSPKX20.050.12
+0.60%
Goldman Sachs US Eq Div and Prem Instl
GSIQX23.62N/A
N/A
Goldman Sachs GQG Ptnrs Intl Opps R
HSIIX29.59-0.08
-0.27%
Carillon Eagle Small Cap Growth I
CCWSX21.56-0.16
-0.74%
Baird Chautauqua International Gr Inv
RYCFX49.56-1.15
-2.27%
Rydex Biotechnology C